AlemtuzumabHyperthyroidism and hypothyroidism: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1791卷 / 1期

关键词：

D O I：

10.1007/s40278-020-74866-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[31] AntineoplasticsSubclinical hypothyroidism, subclinical hyperthyroidism and overt hypothyroidism: 4 case reports
Reactions Weekly, 2021, 1840 (1) : 46 - 46
[32] NivolumabPrimary hypothyroidism and thyrotoxicosis: 17 case reports
Reactions Weekly, 2019, 1761 (1) : 278 - 278
[33] Hyperinsulinism associated with hypothyroidism - Two case reports
Carmichael, JL
ANNALS OF INTERNAL MEDICINE, 1938, 11 (10) : 1906 - 1911
[34] Ipilimumab/nivolumabHypoadrenalism and hypothyroidism: 7 case reports
Reactions Weekly, 2023, 1984 (1) : 285 - 285
[35] Camrelizumab/lenvatinibHypertension and hypothyroidism: 2 case reports
Reactions Weekly, 2024, 2035 (1) : 126 - 126
[36] IodineSevere hypothyroidism in neonates: 2 case reports
Reactions Weekly, 2010, 1295-1296 (1) : 26 - 26
[37] Povidone iodineAcquired hypothyroidism: 2 case reports
Reactions Weekly, 2015, 1561 (1) : 148 - 148
[38] NivolumabHypothyroidism and worsening of hypothyroidism: 2 case reports
Reactions Weekly, 2018, 1721 (1) : 214 - 214
[39] Streptomycin/etoposideOtotoxicity and hypothyroidism: 2 case reports
Reactions Weekly, 2021, 1874 (1) : 246 - 246
[40] Multiple drugsCentral hypothyroidism: 7 case reports
Reactions Weekly, 2023, 1952 (1) : 234 - 234

← 1 2 3 4 5 →